GSA CAPITAL PARTNERS LLP – Mersana Therapeutics, Inc. Transaction History
GSA CAPITAL PARTNERS LLP portfolio value:
$1.12M
portfolio value
GSA CAPITAL PARTNERS LLP quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.04% | -1.75K shares | 349K | $6.76 | 166.99K |
| Q2 2022 | share | Increase | +114.40% | 90.03K shares | 466K | $4.62 | 168.74K |
| Q1 2022 | share | Decrease | -9.60% | -8.35K shares | -228K | $3.99 | 78.70K |
| Q4 2021 | share | Increase | 0.00% | 87.06K shares | 542K | $6.4 | 87.06K |
| Q3 2020 | share | Decrease | -100.00% | -9.03K shares | -212K | $18.62 | 0 |
| Q2 2020 | share | Increase | 0.00% | 9.03K shares | 212K | $23.4 | 9.03K |